Sleepiness in Parkinson's disease: A controlled study
Identifieur interne : 005B56 ( Main/Merge ); précédent : 005B55; suivant : 005B57Sleepiness in Parkinson's disease: A controlled study
Auteurs : Matthew A. Brodsky [États-Unis] ; James Godbold [États-Unis] ; Tom Roth [États-Unis] ; C. Warren Olanow [États-Unis]Source :
- Movement Disorders [ 0885-3185 ] ; 2003-06.
English descriptors
- KwdEn :
- Adult, Aged, Analysis of Variance, Antiparkinson Agents (contraindications), Antiparkinson Agents (therapeutic use), Disorders of Excessive Somnolence (chemically induced), Disorders of Excessive Somnolence (etiology), Female, Humans, Levodopa (contraindications), Levodopa (therapeutic use), Male, Middle Aged, Parkinson Disease (complications), Parkinson Disease (drug therapy), Parkinson's disease, Questionnaires, Sleep Stages, dopamine agonists, driving, sleep episode, somnolence.
- MESH :
- chemical , contraindications : Antiparkinson Agents, Levodopa.
- chemical , therapeutic use : Antiparkinson Agents, Levodopa.
- chemically induced : Disorders of Excessive Somnolence.
- complications : Parkinson Disease.
- drug therapy : Parkinson Disease.
- etiology : Disorders of Excessive Somnolence.
- Adult, Aged, Analysis of Variance, Female, Humans, Male, Middle Aged, Questionnaires, Sleep Stages.
Abstract
Sudden‐onset sleep episodes while driving have been reported in Parkinson's disease (PD) patients, and termed sleep attacks because they were reported to be irresistible and to occur without warning. We postulate that these episodes are due to excessive daytime sleepiness secondary to the high frequency of sleep disorders in PD patients and the sedative effects of dopaminergic medications. We assessed the frequency and relationship between excess daytime sleepiness and sleep episodes while driving (SE) in patients with PD. We evaluated 101 consecutive PD patients presenting to the Movement Disorder Center at the Mount Sinai School of Medicine using a questionnaire that incorporated a subjective estimate of sleepiness, the Epworth Sleepiness Scale (ESS) and information on disease severity and dopaminergic medications. One hundred age‐matched respondents without PD served as a control population. Excess daytime sleepiness was reported in 76% of PD patients compared to 47% of controls (P < 0.05). The mean ESS scores for PD patients was 9.1 ± 6.1 versus 5.7 ± 4.4 in controls (P < 0.001). ESS scores ≥10 were observed in 40.6% of PD patients compared to 19% of controls (P < 0.01) and 24% of PD patients had scores ≥15, compared to 5% of controls (P < 0.001). Sleep episodes while driving were experienced by 20.8% of PD drivers compared to 6% of control drivers (P < 0.05). The mean daily levodopa (L‐dopa) dose equivalent was 1,142 ± 858 mg in PD drivers who experienced a SE while driving compared to 626 ± 667 mg in those who had not (P < 0.05). Similarly, ESS was significantly greater in drivers with a SE than in those without (11.6 ± 6.4 vs. 8.4 ± 4.1; P < 0.05). Logistic regression analysis demonstrated that ESS and mean daily L‐dopa dose equivalents were predictors of sleep episodes while driving, whereas age, gender, disease severity, and individual dopaminergic agents were not. These findings support the notion that sleep episodes while driving in PD patients are related to excess daytime sleepiness and dopaminergic load. Physicians should advise and treat patients accordingly. © 2003 Movement Disorder Society
Url:
DOI: 10.1002/mds.10429
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001078
- to stream Istex, to step Curation: 001078
- to stream Istex, to step Checkpoint: 002863
- to stream PubMed, to step Corpus: 003773
- to stream PubMed, to step Curation: 003773
- to stream PubMed, to step Checkpoint: 003631
- to stream Ncbi, to step Merge: 000A78
- to stream Ncbi, to step Curation: 000A78
- to stream Ncbi, to step Checkpoint: 000A78
Links to Exploration step
ISTEX:BB0A249038EECB8E7D50F47926D718ADC9326591Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Sleepiness in Parkinson's disease: A controlled study</title>
<author><name sortKey="Brodsky, Matthew A" sort="Brodsky, Matthew A" uniqKey="Brodsky M" first="Matthew A." last="Brodsky">Matthew A. Brodsky</name>
</author>
<author><name sortKey="Godbold, James" sort="Godbold, James" uniqKey="Godbold J" first="James" last="Godbold">James Godbold</name>
</author>
<author><name sortKey="Roth, Tom" sort="Roth, Tom" uniqKey="Roth T" first="Tom" last="Roth">Tom Roth</name>
</author>
<author><name sortKey="Olanow, C Warren" sort="Olanow, C Warren" uniqKey="Olanow C" first="C. Warren" last="Olanow">C. Warren Olanow</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:BB0A249038EECB8E7D50F47926D718ADC9326591</idno>
<date when="2003" year="2003">2003</date>
<idno type="doi">10.1002/mds.10429</idno>
<idno type="url">https://api.istex.fr/document/BB0A249038EECB8E7D50F47926D718ADC9326591/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001078</idno>
<idno type="wicri:Area/Istex/Curation">001078</idno>
<idno type="wicri:Area/Istex/Checkpoint">002863</idno>
<idno type="wicri:doubleKey">0885-3185:2003:Brodsky M:sleepiness:in:parkinson</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:12784270</idno>
<idno type="wicri:Area/PubMed/Corpus">003773</idno>
<idno type="wicri:Area/PubMed/Curation">003773</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003631</idno>
<idno type="wicri:Area/Ncbi/Merge">000A78</idno>
<idno type="wicri:Area/Ncbi/Curation">000A78</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000A78</idno>
<idno type="wicri:doubleKey">0885-3185:2003:Brodsky M:sleepiness:in:parkinson</idno>
<idno type="wicri:Area/Main/Merge">005B56</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Sleepiness in Parkinson's disease: A controlled study</title>
<author><name sortKey="Brodsky, Matthew A" sort="Brodsky, Matthew A" uniqKey="Brodsky M" first="Matthew A." last="Brodsky">Matthew A. Brodsky</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Mount Sinai School of Medicine, New York, New York</wicri:regionArea>
<placeName><region type="state">État de New York</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Godbold, James" sort="Godbold, James" uniqKey="Godbold J" first="James" last="Godbold">James Godbold</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Mount Sinai School of Medicine, New York, New York</wicri:regionArea>
<placeName><region type="state">État de New York</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Roth, Tom" sort="Roth, Tom" uniqKey="Roth T" first="Tom" last="Roth">Tom Roth</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Henry Ford Hospital, Detroit, Michigan</wicri:regionArea>
<placeName><region type="state">Michigan</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Olanow, C Warren" sort="Olanow, C Warren" uniqKey="Olanow C" first="C. Warren" last="Olanow">C. Warren Olanow</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Mount Sinai School of Medicine, New York, New York</wicri:regionArea>
<placeName><region type="state">État de New York</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2003-06">2003-06</date>
<biblScope unit="vol">18</biblScope>
<biblScope unit="issue">6</biblScope>
<biblScope unit="page" from="668">668</biblScope>
<biblScope unit="page" to="672">672</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">BB0A249038EECB8E7D50F47926D718ADC9326591</idno>
<idno type="DOI">10.1002/mds.10429</idno>
<idno type="ArticleID">MDS10429</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Analysis of Variance</term>
<term>Antiparkinson Agents (contraindications)</term>
<term>Antiparkinson Agents (therapeutic use)</term>
<term>Disorders of Excessive Somnolence (chemically induced)</term>
<term>Disorders of Excessive Somnolence (etiology)</term>
<term>Female</term>
<term>Humans</term>
<term>Levodopa (contraindications)</term>
<term>Levodopa (therapeutic use)</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Parkinson Disease (complications)</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Parkinson's disease</term>
<term>Questionnaires</term>
<term>Sleep Stages</term>
<term>dopamine agonists</term>
<term>driving</term>
<term>sleep episode</term>
<term>somnolence</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="contraindications" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Disorders of Excessive Somnolence</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Disorders of Excessive Somnolence</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Analysis of Variance</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Questionnaires</term>
<term>Sleep Stages</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Sudden‐onset sleep episodes while driving have been reported in Parkinson's disease (PD) patients, and termed sleep attacks because they were reported to be irresistible and to occur without warning. We postulate that these episodes are due to excessive daytime sleepiness secondary to the high frequency of sleep disorders in PD patients and the sedative effects of dopaminergic medications. We assessed the frequency and relationship between excess daytime sleepiness and sleep episodes while driving (SE) in patients with PD. We evaluated 101 consecutive PD patients presenting to the Movement Disorder Center at the Mount Sinai School of Medicine using a questionnaire that incorporated a subjective estimate of sleepiness, the Epworth Sleepiness Scale (ESS) and information on disease severity and dopaminergic medications. One hundred age‐matched respondents without PD served as a control population. Excess daytime sleepiness was reported in 76% of PD patients compared to 47% of controls (P < 0.05). The mean ESS scores for PD patients was 9.1 ± 6.1 versus 5.7 ± 4.4 in controls (P < 0.001). ESS scores ≥10 were observed in 40.6% of PD patients compared to 19% of controls (P < 0.01) and 24% of PD patients had scores ≥15, compared to 5% of controls (P < 0.001). Sleep episodes while driving were experienced by 20.8% of PD drivers compared to 6% of control drivers (P < 0.05). The mean daily levodopa (L‐dopa) dose equivalent was 1,142 ± 858 mg in PD drivers who experienced a SE while driving compared to 626 ± 667 mg in those who had not (P < 0.05). Similarly, ESS was significantly greater in drivers with a SE than in those without (11.6 ± 6.4 vs. 8.4 ± 4.1; P < 0.05). Logistic regression analysis demonstrated that ESS and mean daily L‐dopa dose equivalents were predictors of sleep episodes while driving, whereas age, gender, disease severity, and individual dopaminergic agents were not. These findings support the notion that sleep episodes while driving in PD patients are related to excess daytime sleepiness and dopaminergic load. Physicians should advise and treat patients accordingly. © 2003 Movement Disorder Society</div>
</front>
</TEI>
<double doi="10.1002/mds.10429"><ISTEX><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Sleepiness in Parkinson's disease: A controlled study</title>
<author><name sortKey="Brodsky, Matthew A" sort="Brodsky, Matthew A" uniqKey="Brodsky M" first="Matthew A." last="Brodsky">Matthew A. Brodsky</name>
</author>
<author><name sortKey="Godbold, James" sort="Godbold, James" uniqKey="Godbold J" first="James" last="Godbold">James Godbold</name>
</author>
<author><name sortKey="Roth, Tom" sort="Roth, Tom" uniqKey="Roth T" first="Tom" last="Roth">Tom Roth</name>
</author>
<author><name sortKey="Olanow, C Warren" sort="Olanow, C Warren" uniqKey="Olanow C" first="C. Warren" last="Olanow">C. Warren Olanow</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:BB0A249038EECB8E7D50F47926D718ADC9326591</idno>
<date when="2003" year="2003">2003</date>
<idno type="doi">10.1002/mds.10429</idno>
<idno type="url">https://api.istex.fr/document/BB0A249038EECB8E7D50F47926D718ADC9326591/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001078</idno>
<idno type="wicri:Area/Istex/Curation">001078</idno>
<idno type="wicri:Area/Istex/Checkpoint">002863</idno>
<idno type="wicri:doubleKey">0885-3185:2003:Brodsky M:sleepiness:in:parkinson</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Sleepiness in Parkinson's disease: A controlled study</title>
<author><name sortKey="Brodsky, Matthew A" sort="Brodsky, Matthew A" uniqKey="Brodsky M" first="Matthew A." last="Brodsky">Matthew A. Brodsky</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Mount Sinai School of Medicine, New York, New York</wicri:regionArea>
<placeName><region type="state">État de New York</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Godbold, James" sort="Godbold, James" uniqKey="Godbold J" first="James" last="Godbold">James Godbold</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Mount Sinai School of Medicine, New York, New York</wicri:regionArea>
<placeName><region type="state">État de New York</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Roth, Tom" sort="Roth, Tom" uniqKey="Roth T" first="Tom" last="Roth">Tom Roth</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Henry Ford Hospital, Detroit, Michigan</wicri:regionArea>
<placeName><region type="state">Michigan</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Olanow, C Warren" sort="Olanow, C Warren" uniqKey="Olanow C" first="C. Warren" last="Olanow">C. Warren Olanow</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Mount Sinai School of Medicine, New York, New York</wicri:regionArea>
<placeName><region type="state">État de New York</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2003-06">2003-06</date>
<biblScope unit="vol">18</biblScope>
<biblScope unit="issue">6</biblScope>
<biblScope unit="page" from="668">668</biblScope>
<biblScope unit="page" to="672">672</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">BB0A249038EECB8E7D50F47926D718ADC9326591</idno>
<idno type="DOI">10.1002/mds.10429</idno>
<idno type="ArticleID">MDS10429</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Parkinson's disease</term>
<term>dopamine agonists</term>
<term>driving</term>
<term>sleep episode</term>
<term>somnolence</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Sudden‐onset sleep episodes while driving have been reported in Parkinson's disease (PD) patients, and termed sleep attacks because they were reported to be irresistible and to occur without warning. We postulate that these episodes are due to excessive daytime sleepiness secondary to the high frequency of sleep disorders in PD patients and the sedative effects of dopaminergic medications. We assessed the frequency and relationship between excess daytime sleepiness and sleep episodes while driving (SE) in patients with PD. We evaluated 101 consecutive PD patients presenting to the Movement Disorder Center at the Mount Sinai School of Medicine using a questionnaire that incorporated a subjective estimate of sleepiness, the Epworth Sleepiness Scale (ESS) and information on disease severity and dopaminergic medications. One hundred age‐matched respondents without PD served as a control population. Excess daytime sleepiness was reported in 76% of PD patients compared to 47% of controls (P < 0.05). The mean ESS scores for PD patients was 9.1 ± 6.1 versus 5.7 ± 4.4 in controls (P < 0.001). ESS scores ≥10 were observed in 40.6% of PD patients compared to 19% of controls (P < 0.01) and 24% of PD patients had scores ≥15, compared to 5% of controls (P < 0.001). Sleep episodes while driving were experienced by 20.8% of PD drivers compared to 6% of control drivers (P < 0.05). The mean daily levodopa (L‐dopa) dose equivalent was 1,142 ± 858 mg in PD drivers who experienced a SE while driving compared to 626 ± 667 mg in those who had not (P < 0.05). Similarly, ESS was significantly greater in drivers with a SE than in those without (11.6 ± 6.4 vs. 8.4 ± 4.1; P < 0.05). Logistic regression analysis demonstrated that ESS and mean daily L‐dopa dose equivalents were predictors of sleep episodes while driving, whereas age, gender, disease severity, and individual dopaminergic agents were not. These findings support the notion that sleep episodes while driving in PD patients are related to excess daytime sleepiness and dopaminergic load. Physicians should advise and treat patients accordingly. © 2003 Movement Disorder Society</div>
</front>
</TEI>
</ISTEX>
<PubMed><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Sleepiness in Parkinson's disease: a controlled study.</title>
<author><name sortKey="Brodsky, Matthew A" sort="Brodsky, Matthew A" uniqKey="Brodsky M" first="Matthew A" last="Brodsky">Matthew A. Brodsky</name>
<affiliation wicri:level="1"><nlm:affiliation>Mount Sinai School of Medicine, New York, New York 10029, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Mount Sinai School of Medicine, New York, New York 10029</wicri:regionArea>
<wicri:noRegion>New York 10029</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Godbold, James" sort="Godbold, James" uniqKey="Godbold J" first="James" last="Godbold">James Godbold</name>
</author>
<author><name sortKey="Roth, Tom" sort="Roth, Tom" uniqKey="Roth T" first="Tom" last="Roth">Tom Roth</name>
</author>
<author><name sortKey="Olanow, C Warren" sort="Olanow, C Warren" uniqKey="Olanow C" first="C Warren" last="Olanow">C Warren Olanow</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2003">2003</date>
<idno type="RBID">pubmed:12784270</idno>
<idno type="pmid">12784270</idno>
<idno type="doi">10.1002/mds.10429</idno>
<idno type="wicri:Area/PubMed/Corpus">003773</idno>
<idno type="wicri:Area/PubMed/Curation">003773</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003631</idno>
<idno type="wicri:Area/Ncbi/Merge">000A78</idno>
<idno type="wicri:Area/Ncbi/Curation">000A78</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000A78</idno>
<idno type="wicri:doubleKey">0885-3185:2003:Brodsky M:sleepiness:in:parkinson</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Sleepiness in Parkinson's disease: a controlled study.</title>
<author><name sortKey="Brodsky, Matthew A" sort="Brodsky, Matthew A" uniqKey="Brodsky M" first="Matthew A" last="Brodsky">Matthew A. Brodsky</name>
<affiliation wicri:level="1"><nlm:affiliation>Mount Sinai School of Medicine, New York, New York 10029, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Mount Sinai School of Medicine, New York, New York 10029</wicri:regionArea>
<wicri:noRegion>New York 10029</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Godbold, James" sort="Godbold, James" uniqKey="Godbold J" first="James" last="Godbold">James Godbold</name>
</author>
<author><name sortKey="Roth, Tom" sort="Roth, Tom" uniqKey="Roth T" first="Tom" last="Roth">Tom Roth</name>
</author>
<author><name sortKey="Olanow, C Warren" sort="Olanow, C Warren" uniqKey="Olanow C" first="C Warren" last="Olanow">C Warren Olanow</name>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2003" type="published">2003</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Analysis of Variance</term>
<term>Antiparkinson Agents (contraindications)</term>
<term>Antiparkinson Agents (therapeutic use)</term>
<term>Disorders of Excessive Somnolence (chemically induced)</term>
<term>Disorders of Excessive Somnolence (etiology)</term>
<term>Female</term>
<term>Humans</term>
<term>Levodopa (contraindications)</term>
<term>Levodopa (therapeutic use)</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Parkinson Disease (complications)</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Questionnaires</term>
<term>Sleep Stages</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="contraindications" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Disorders of Excessive Somnolence</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Disorders of Excessive Somnolence</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Analysis of Variance</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Questionnaires</term>
<term>Sleep Stages</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Sudden-onset sleep episodes while driving have been reported in Parkinson's disease (PD) patients, and termed sleep attacks because they were reported to be irresistible and to occur without warning. We postulate that these episodes are due to excessive daytime sleepiness secondary to the high frequency of sleep disorders in PD patients and the sedative effects of dopaminergic medications. We assessed the frequency and relationship between excess daytime sleepiness and sleep episodes while driving (SE) in patients with PD. We evaluated 101 consecutive PD patients presenting to the Movement Disorder Center at the Mount Sinai School of Medicine using a questionnaire that incorporated a subjective estimate of sleepiness, the Epworth Sleepiness Scale (ESS) and information on disease severity and dopaminergic medications. One hundred age-matched respondents without PD served as a control population. Excess daytime sleepiness was reported in 76% of PD patients compared to 47% of controls (P < 0.05). The mean ESS scores for PD patients was 9.1 +/- 6.1 versus 5.7 +/- 4.4 in controls (P < 0.001). ESS scores > or =10 were observed in 40.6% of PD patients compared to 19% of controls (P < 0.01) and 24% of PD patients had scores > or =15, compared to 5% of controls (P < 0.001). Sleep episodes while driving were experienced by 20.8% of PD drivers compared to 6% of control drivers (P < 0.05). The mean daily levodopa (L-dopa) dose equivalent was 1,142 +/- 858 mg in PD drivers who experienced a SE while driving compared to 626 +/- 667 mg in those who had not (P < 0.05). Similarly, ESS was significantly greater in drivers with a SE than in those without (11.6 +/- 6.4 vs. 8.4 +/- 4.1; P < 0.05). Logistic regression analysis demonstrated that ESS and mean daily L-dopa dose equivalents were predictors of sleep episodes while driving, whereas age, gender, disease severity, and individual dopaminergic agents were not. These findings support the notion that sleep episodes while driving in PD patients are related to excess daytime sleepiness and dopaminergic load. Physicians should advise and treat patients accordingly.</div>
</front>
</TEI>
</PubMed>
</double>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005B56 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 005B56 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Main |étape= Merge |type= RBID |clé= ISTEX:BB0A249038EECB8E7D50F47926D718ADC9326591 |texte= Sleepiness in Parkinson's disease: A controlled study }}
![]() | This area was generated with Dilib version V0.6.23. | ![]() |